Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

The Effect of Tai Chi and Therapy by Dance and Movement on Blood Irisin Levels in Older Adults Over 65 Years of Age.

3. Mai 2022 aktualisiert von: Hana Polanska, Charles University, Czech Republic

The aim of this project is to estimate the effects of therapy with dance and movement and Tai Chi on irisin plasma levels, a myokine with proven neuroprotective effects, in the context of baseline levels of cognitive function and physical performance in seniors over 65 years of age.

It is empirically verified that physical activity can have a positive effect on cognitive function even in individuals with mild cognitive impairment. There may be a number of reasons why this is the case. Recently, research investigating the relationship between the secretion of certain myokines and their neuroprotective effects has gained importance. One of these myokines is irisin, which has recently been shown to have beneficial effects on the CNS by upregulating the expression of Brain Derived Neurotrophic Factor (BDNF) in the hippocampus in an animal model. Increased irisin levels as a consequence of exercise have recently been partially demonstrated in humans. What type of physical activity is most effective in terms of its effect on cognitive function in humans is another important scientific challenge. The possibility of influencing endocrine secretion of bioactive substances with proven effects on synaptic plasticity, neurogenesis and neuroprotection through effective therapies may help to combat neurodegenerative diseases, the prevalence of which is increasing with the average age of the population. According to Alzheimer's Disease International, 50 million people worldwide were affected by some form of neurodegenerative disease in 2017. The number of people affected is still rising. It is predicted that this number will reach 75 million sufferers by 2030 (https://www.alz.co.uk/research/statistics). Alzheimer's disease and multiple sclerosis are the two most common manifestations of neurodegenerative diseases. The effect of therapy with dance and movement and the effect of Tai Chi on blood irisin levels in the context of cognitive function and physical performance levels, has not yet been conclusively demonstrated.

Studienübersicht

Detaillierte Beschreibung

It is empirically verified that physical activity can have a positive effect on cognitive function even in individuals with mild cognitive impairment. There may be a number of reasons why this is the case. Recently, research investigating the relationship between the secretion of certain myokines and their neuroprotective effects has gained importance. One of these myokines is irisin, which has recently been shown to have beneficial effects on the CNS by upregulating the expression of Brain Derived Neurotrophic Factor (BDNF) in the hippocampus in an animal model. Increased irisin levels as a consequence of exercise have recently been partially demonstrated in humans. What type of physical activity is most effective in terms of its effect on cognitive function in humans is another important scientific challenge. The possibility of influencing endocrine secretion of bioactive substances with proven effects on synaptic plasticity, neurogenesis and neuroprotection through effective therapies may help to combat neurodegenerative diseases, the prevalence of which is increasing with the average age of the population. According to Alzheimer's Disease International, 50 million people worldwide were affected by some form of neurodegenerative disease in 2017. The number of people affected is still rising. It is predicted that this number will reach 75 million sufferers by 2030 (https://www.alz.co.uk/research/statistics). Alzheimer's disease and multiple sclerosis are the two most common manifestations of neurodegenerative diseases. The effect of therapy with dance and movement and the effect of Tai Chi on blood irisin levels in the context of cognitive function and physical performance levels, has not yet been conclusively demonstrated. The aim of this project is to estimate the effects of therapy with dance and movement and Tai Chi on irisin plasma levels, a myokine with proven neuroprotective effects, in the context of baseline levels of cognitive function and physical performance in seniors over 65 years of age.

Implementation of the project: the following personal data will be collected at the Consultation Room for Memory Disorders, AD Centrum Fakultní at the Královské Vinohrady Hospital (PPP AD FNKV): age, weight, height, sex, education, a brief medical history will be taken, current illness and current treatment will be determined, and a basic pharmacological and toxicological history will be taken. The probands who will be admitted to the experimental part of the project, based on the initial screening at the PPP AD FNKV, will have their cognitive function tested and 9 ml of venous blood drawn before and after the intervention at the PPP AD FNKV, and strength and physical performance tested at the UK FTVS. Thereafter, probands will be randomized to either the intervention groups or the control group. This randomized controlled trial will compare the effects of a movement and dance therapy based on Bartenieff fundamentals and the other type of intervention will be implemented as Tai Chi exercises. Both types of exercises are designed to place a greater emphasis on body perception, so that there is a connection between musculoskeletal coordination and movement in conjunction with an emotional experience focused on the ability to perceive bodily signals. This approach will activate cognitive functions more. The experimental part will be carried out with a time intensity of twice a week (90 min) for 12 weeks - all in two phases 09-2021 to 12-2021 and 09-2022 to 12-2022. The control group will be implemented on the principle of wait-list control group.

Characteristics of research participants: Based on the power analysis, we expect to recruit approximately 90 participants (age ≥ 65 - ≤ 80 years) from outpatients of the PPP AD FNKV and U3V UK FTVS participants, or other interested persons from Prague 6.

Individuals with advanced cognitive impairment, regular use of medications affecting cognitive performance, antidepressants, anxiolytics, and individuals with uncorrected hypertension and ischemic heart disease, acutee (especially infectious) disease, musculoskeletal disorders and chronic diseases limiting physical activity, as well as individuals in recovery after illness or injury cannot take part in the study.

Ethical aspects of research: The research will be conducted on seniors who will be enrolled in the research on the basis of voluntary informed consent. Since movement therapy has no negative side effects, it is an ethically conflict-free research from this perspective. On the other hand, a great benefit to society can be expected, in particular the development of a suitable exercise regimen that will be applicable to other age groups. Since the elderly are a specific and relatively easy to influence group, they will be adequately informed about the purpose of the research, and the benefits of the research for them and for the elderly population as a whole will be explained. Before signing the informed consent, the clarity and understanding of the information provided will be carefully checked.

Studientyp

Interventionell

Einschreibung (Voraussichtlich)

90

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

      • Prague, Tschechien
        • Rekrutierung
        • Faculty Hospital Vinohrady
        • Kontakt:
      • Prague, Tschechien
        • Rekrutierung
        • Faculty of Physical Education and Sport
        • Kontakt:

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

65 Jahre bis 80 Jahre (Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Is 65 years - 80 years in age
  • His/her native language is Czech
  • Is willing to visit the testing centre two times within 3-4 months
  • Is willing to provide blood samples twice
  • Is willing to take part in the movement therapy intervention
  • is self-sufficient (handling finances, travelling without a chaperone, administration of medication, correct phone usage, filling forms, meal preparation)
  • Has good vision; Can read and write, glasses are acceptable
  • Has good hearing to hear and understand all instructions during examination
  • Can walk well (walking aids are acceptable) to attend all the examinations and move well enough to take part in the movement therapy

Exclusion Criteria:

  • Had been treated/Is currently being treated for the following psychiatric disorders: alcohol/medication/drug of abuse dependance, schizophrenia, psychotic disorder, bipolar disorder
  • Had larger physical imparment which would interfere with the ability to take part in the Dance Movement and Tai Chi interventions
  • Had severe neurological difficulties (epilepsy, stroke, severe head trauma, meningitis in the past 10 years, brain surgery, brain tumour, prolonged period(s) in an unconscious state - excluding general anaesthesia)
  • Underwent a surgery/procedure under general anaesthesia in the past three years or has a planned procedure/surgery under general anaesthesia in the next 6 months over the course of this trial
  • Is taking medication for depression or low mood

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Verhütung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Therapy by Dance and Movement
Participants assigned to this part take part in Dance Movement Therapy twice a week (90 minutes each) for the duration of three months.
Therapy by dance and movement is based on the principals of movement-analysis by Rudolf Laban and Irmgard Bartenieff. Participants will attend sessions twice a week (90 minutes each) for the duration of three months.
Kein Eingriff: Control to Dance Movement Therapy
Participants assigned to this arm take part in no particular activity for the three months.
Experimental: Movement Therapy by Tai Chi
Participants assigned to this part take part inTai Chi class twice a week (90 minutes each) for the duration of three months.
Tai Chi is based on somatic approach. Participants will attend sessions twice a week (90 minutes each) for the duration of three months.
Kein Eingriff: Control to Tai Chi
Participants assigned to this arm take part in no particular activity for the three months.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Irisin blood levels after 3 months of the intervention
Zeitfenster: baseline to 3 months
Irisin levels measured from 9ml blood samples
baseline to 3 months
Difference in Irisin blood levels between the arms at 3 months
Zeitfenster: 3 months
Irisin levels measured from 9ml blood samples
3 months

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in brain derived neurotrophic factor (BDNF) levels at 3 months
Zeitfenster: baseline to 3 months
BDNF measured from a 9ml blood samples.
baseline to 3 months
Difference in brain derived neurotrophic factor (BDNF) levels at 3 months between the arms
Zeitfenster: 3 months
BDNF measured from a 9ml blood samples.
3 months
Change from baseline cognitive function in the Amnesia Light and Brief Assessment (ALBA) at 3 months better outcome
Zeitfenster: baseline to 3 months
ALBA is a validated measure assessing memory. The scale spans 0-12 points with higher number of points signifying better outcome
baseline to 3 months
Difference in cognitive function in the Amnesia Light and Brief Assessment (ALBA) between the arms at 3 months
Zeitfenster: 3 months
ALBA is a validated measure assessing memory. The scale spans 0-12 points with higher number of points signifying better outcome
3 months
Veränderung der kognitiven Grundfunktion bei der Erinnerung an semantische Wörter (Kategorie: Tiere, 1 Minute) nach 3 Monaten
Zeitfenster: Grundlinie auf 3 Monate
Die semantische Worterinnerung ist ein Maß für die kognitive Funktion. Die Ergebnisse reichen von 0 bis ca. 40, mehr Punkte bedeuten ein besseres Ergebnis
Grundlinie auf 3 Monate
Difference in cognitive function in Semantic word recollection (category: animals, 1 min) between the arms at 3 months
Zeitfenster: 3 months
Semantic word recollection is a measure of cognitive function, results range from 0-cca 40, more points signify better outcome
3 months
Change in cognitive function in Semantic word recollection (category: letters, 1 min) at 3 months
Zeitfenster: baseline to 3 months
Semantic word recollection is a measure of cognitive function, results range from 0-cca 40, more points signify better outcome
baseline to 3 months
Difference in cognitive function in Semantic word recollection (category: letters, 1 min) at 3 months between the arms
Zeitfenster: 3 months
Semantic word recollection is a measure of cognitive function, results range from 0-cca 40, more points signify better outcome
3 months
Veränderung der kognitiven Grundfunktion im Rey Auditory Verbal Learning Test (RAVLT) nach 3 Monaten
Zeitfenster: Grundlinie auf 3 Monate
RAVLT ist ein validiertes Maß für die kognitive Funktion. Es verfügt über 8 Unterskalen, die jeweils von 0 bis 15 reichen und in Rohwerten gemessen werden, die mit der altersabhängigen Bevölkerungsnorm verknüpft sind
Grundlinie auf 3 Monate
Difference in cognitive function in Rey Auditory Verbal Learning Test (RAVLT) at 3 months between the arms
Zeitfenster: 3 months
RAVLT is a validated measure of cognitive function, it has 8 subscales, each of them ranging from 0-15, measured in raw scores which are connected to age-dependent population norm
3 months
Veränderung der grundlegenden kognitiven Funktion in der Wechsler Adult Intelligence Scale, dritte Ausgabe (WAIS III) – Untertest „Symbole“ nach 3 Monaten
Zeitfenster: Grundlinie auf 3 Monate
Der WAIS III-Untertest „Symbole“ ist ein validiertes Maß für die kognitive Funktion. Die Punkteskala reicht von 0 bis 133, wobei eine höhere Punktzahl ein besseres Ergebnis signalisiert
Grundlinie auf 3 Monate
Difference in cognitive function in Wechsler Adult Intelligence Scale, Third edition (WAIS III) - "Symbols" subtest at 3 months between the arms
Zeitfenster: 3 months
The WAIS III, subtest "Symbols" is a validated measure of cognitive function, the point scale ranges from 0-133 with larger point attainment signalling better outcome
3 months
Veränderung der kognitiven Grundfunktion im Trail Making Test (TMT), Teile A und B nach 3 Monaten
Zeitfenster: Grundlinie auf 3 Monate
Der TMT ist ein validiertes Maß für die kognitive Funktion, gemessen wird die Zeit bis zum Abschluss
Grundlinie auf 3 Monate
Difference in cognitive function in Trail Making Test (TMT), Parts A & B at 3 months between the arms
Zeitfenster: 3 months
The TMT is a validated measure of cognitive function, the time upon completion is measured
3 months
Change in the Clock Drawing Test at 3 months
Zeitfenster: baseline to 3 months
A validated measure where participant is asked to draw a clock face with the time 23:20
baseline to 3 months
Difference in the Clock Drawing Test at 3 months between the arms
Zeitfenster: 3 months
A validated measure where participant is asked to draw a clock face with the time 23:20
3 months
Change in Line Picture Production test at 3 months
Zeitfenster: baseline to 3 months
Participant is asked to produce as many as possible pictures consisting from 4 straight lines in 1 minute.
baseline to 3 months
Difference in Line Picture Production test at 3 months between the arms
Zeitfenster: 3 months
Participant is asked to produce as many as possible pictures consisting from 4 straight lines in 1 minute.
3 months
Change in Picture Naming and Immediate Recall test (PICNIR) at 3 months
Zeitfenster: Baseline to 3 months
Cognitive measure where participants first write down names of 20 pictures and then are asked to recall these names within 1 minute
Baseline to 3 months
Difference in Picture Naming and Immediate Recall test (PICNIR) at 3 months between the arms
Zeitfenster: 3 months
Cognitive measure where participants first write down names of 20 pictures and then are asked to recall these names within 1 minute.
3 months
Change in baseline mood in Geriatric Depression Scale at 3 months.
Zeitfenster: baseline to 3 months
A self-report measure of mood, measured on 0-15 point scale, higher point attainment signifies worse outcome.
baseline to 3 months
Difference in mood in Geriatric Depression Scale at 3 months.
Zeitfenster: 3 months
A self-report measure of mood, measured on 0-15 point scale, higher point attainment signifies worse outcome.
3 months
Änderung der im Fragebogen zum funktionellen Zustand (Abkürzung in der Originalsprache: subjektive FAQ-CZ) selbst gemeldeten Ausgangsselbstständigkeit nach 3 Monaten
Zeitfenster: Grundlinie auf 3 Monate
FAQ-CZ ist ein Selbstbericht zur Messung der Selbstständigkeit. Er wird auf einer Skala von 0 bis 30 gemessen, wobei ein höherer erreichter Punkt ein schlechteres Ergebnis anzeigt
Grundlinie auf 3 Monate
Difference in self-sufficiency self-reported in Questionnaire of functional state (abbreviation in original language: subjective FAQ-CZ) at 3 months between the arms
Zeitfenster: 3 months
FAQ-CZ is a self-report measure of self-sufficiency, it is measured on a scale of 0-30 with higher point attainment signalling worse outcome
3 months
Change in Sarcopenia at 3 months
Zeitfenster: baseline to 3 months
An ultrasound imaging method for diagnosing sarcopenia based on changes in muscle geometric proportions: muscle thickness (MT), pennation angle (PA), fiber length (FL), and ultrasound sarcopenic index (USI) calculated as FL/MT.
baseline to 3 months
Difference in Sarcopenia at 3 months between the arms
Zeitfenster: 3 months
An ultrasound imaging method for diagnosing sarcopenia based on changes in muscle geometric proportions: muscle thickness (MT), pennation angle (PA), fiber length (FL), and ultrasound sarcopenic index (USI) calculated as FL/MT.
3 months
Change in knee extensor isometric strength and static fatigue at 3 months
Zeitfenster: baseline to 3 months
Knee extensor isometric strength and static fatigue were measured by a stationary dynamometer: isometric torque (Nm), and fatigue index calculated as the Area Under Force vs. Time Curve of right knee extensor during a sustained 30 s maximal voluntary muscle contraction. Handgrip strength.
baseline to 3 months
Difference in knee extensor isometric strength and static fatigue at 3 months between the arms
Zeitfenster: 3 months
Knee extensor isometric strength and static fatigue were measured by a stationary dynamometer: isometric torque (Nm), and fatigue index calculated as the Area Under Force vs. Time Curve of right knee extensor during a sustained 30 s maximal voluntary muscle contraction. Handgrip strength.
3 months
Change in short physical performance battery (SPPB) at 3 months
Zeitfenster: baseline to 3 months
The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests. It is used as a predictive tool for possible disability and can aid in the monitoring of function in older people.
baseline to 3 months
Difference in short physical performance battery (SPPB) at 3 months between the arms
Zeitfenster: 3 months
The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests. It is used as a predictive tool for possible disability and can aid in the monitoring of function in older people.
3 months
Change in Body Composition at 3 months
Zeitfenster: baseline to 3 months
Body composition by a bioelectrical impedance analysis (BIA).
baseline to 3 months
Difference in Body Composition at 3 months between the arms
Zeitfenster: 3 months
Body composition by a bioelectrical impedance analysis (BIA).
3 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. August 2021

Primärer Abschluss (Voraussichtlich)

30. Januar 2023

Studienabschluss (Voraussichtlich)

30. Januar 2023

Studienanmeldedaten

Zuerst eingereicht

3. Mai 2022

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

3. Mai 2022

Zuerst gepostet (Tatsächlich)

5. Mai 2022

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

5. Mai 2022

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

3. Mai 2022

Zuletzt verifiziert

1. Mai 2022

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

UNENTSCHIEDEN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren